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1. Introduction 22 
Polybrominated diphenyl ethers (PBDEs) are compounds that are used to reduce the 23 
flammability of commercial and household items (Alaee et al. 2003; Alaee and Wenning 24 
2002).  Three commercial PBDE formulations have been produced: penta-BDE, octa-BDE 25 
and deca-BDE.    The penta-BDE product was used mainly in flexible polyurethane foam 26 
for mattresses and cushioning, octa-BDE in the plastics industry in computer casings and 27 
monitors and deca-BDE in high impact polystyrenes and other materials for electronic and 28 
electrical appliances, the automotive industry, construction and building applications as 29 
well as textiles (Department of Health and Human Services 2004).  In Australia, 30 
importation of the penta- and octa-BDE products ceased in 2005 (NICNAS 2007).   31 
 32 
PBDEs may leach or volatilise from products (Darnerud et al. 2001) and enter the 33 
environment thus resulting in human exposure to these persistent, lipophilic chemicals.  34 
There is cause for concern regarding PBDE exposure as animal studies report 35 
developmental, reproductive and neurotoxic effects as well as endocrine disruption 36 
following PBDE exposure (Birnbaum 2007).  The limited human data show concentrations 37 
in human milk to be associated with congenital cryptorchidism (Main et al. 2007); and 38 
lower birth weight, length and chest circumference (Chao et al. 2007).  39 
 40 
Concentrations of PBDEs in human samples of blood and milk show large variation 41 
between countries ranging from < 1 ng/g lipid in some Asian (e.g. Akutsu et al. 2003; 42 
Sudaryanto et al. 2008) and European (e.g. Fürst 2006; Ingelido et al. 2007; Raab et al. 43 
2008) countries to around 100 ng/g lipid in samples collected in Canada (Sandanger et al. 44 
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2007) and the USA (Fischer et al. 2006; Schecter et al. 2003).  The sources and pathways of 45 
human PBDE exposure are still under investigation although have been suggested to 46 
include: dietary sources (e.g. Darnerud et al. 2006; Domingo et al. 2008; Gomara et al. 47 
2006), inhalation and dust ingestion in indoor domestic and workplace environments as 48 
well as in cars and planes (e.g. Allen et al. 2007; Christiansson et al. 2008; Harrad et al. 49 
2006; Mandalakis et al. 2008; Wilford et al. 2005).  Some assessments of overall PBDE 50 
exposure demonstrated dust as being a primary route of exposure for the American 51 
population rather than food (Jones-Otazo et al. 2005; Lorber 2008) while our studies to date 52 
have indicated that in Australia food is expected to be the greatest contributor to intake of 53 
PBDEs (Toms et al. 2008).  However, the contribution of dust to the total intake of PBDEs 54 
is dependant on the rate of dust ingestion used which typically varies between studies.  For 55 
example, Lorber (2008) assumes 100 mg/day ingestion for children and 50 mg/day for 56 
adults.  By contrast, we have assumed 50 mg/day for childhood ingestion dropping to less 57 
than 10 mg/day for older children and adults (Toms et al, 2008).          58 
 59 
Few studies have used matched samples to investigate exposure pathways and human 60 
PBDE body burden.  Wu et al. (2007) in the USA and Karlsson et al. (2007) in Sweden 61 
found positive associations between PBDE concentrations in human milk/ plasma and dust 62 
while, Sharp and Lunder (2004) in the USA found no such correlation.   63 
 64 
Our previous studies on PBDEs in humans in Australia have focused on assessment of 65 
geographical, gender and/or age related trends (Toms et al. 2007; Toms et al. 2008).  In 66 
conducting these studies, we pooled either human milk (Toms et al. 2007) or blood serum 67 
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(Toms et al. 2008).  We have also carried out studies to assess the concentrations of these 68 
chemicals in air, dust and also surface wipes (Kennedy et al. 2008; Toms et al. 2008 - 69 
submitted).  However we have not assessed whether a link can be established between the 70 
concentration of PBDEs in individuals and the respective PBDE concentrations in their 71 
indoor environment.  The aim of this study was to conduct an integrated assessment of 72 
PBDE exposure and individual human body burden using matched samples of human milk, 73 
indoor air and dust collected from 10 mothers in 2007-2008 in Brisbane, Australia.  In 74 
addition, the concentrations of PBDEs in human milk will be compared to data from 75 
samples collected in 2002-2003 to assess whether a temporal trend exists. 76 
 77 
2. Materials and Methods 78 
 79 
The University of Queensland Medical Research Ethics Committee approved the study and 80 
all participants read and signed a participant information sheet and consent form.   81 
 82 
2.1. Sample collection and analysis 83 
 84 
2.1.1. Human milk 85 
Ten mothers residing in Brisbane, Queensland, Australia donated milk samples.  Maternal 86 
age ranged from 27 to 40 years and eight donors were primiparous.  Mothers were recruited 87 
by word-of-mouth through friends and colleagues of the researchers.  Infant age at the time 88 
of sample collection ranged from 2 to 11 months and six were male.  Mothers completed a 89 
self-administered questionnaire yielding information on demographics, diet, house 90 
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characteristics and daily time spent at a computer and in a car, in an attempt to identify 91 
sources and factors that may impact the concentrations of PBDEs in the mother’s 92 
microenvironment.   93 
 94 
The mothers donated ~100 ml of human milk collected either using a pump or by directly 95 
expressing the milk into the glass container that was provided by the study team.  Sample 96 
collection occurred between April 2007 and April 2008 and for most mothers within a 97 
month of air and dust sampling.  When all milk samples were collected, each was defrosted, 98 
thoroughly homogenised and 50 ml was aliquoted into a glass jar.  Samples were then 99 
refrozen and transported on dry ice to Eurofins/ERGO, Hamburg, Germany where they 100 
were received in good condition.  One duplicate sample was included for quality control/ 101 
quality assurance. 102 
 103 
The following congeners were targeted: BDE- 1, -2, -3, -7, -10, -13, -15, -17, -25, -28, -35, 104 
-47, -49, -66, -71, -75, -77, -85, -99, -100, -116, -119, -126, -138, -140, -153, -154, -155, -105 
156, -181, -183, -197, -203, -207 and -209.  Samples were extracted using ultra-trace 106 
solvents.  Before extraction the following internal standards were added to the samples: 107 
BDEs- 3, -15, -28, -47, -99, -153, -154, -183, -197, -207 and -209 (all 13C-UL labeled).  108 
The lipid content was determined by gravimetry and averaged 2.9 %.  The sample extract 109 
was taken up in n-hexane, treated by a clean-up including H2SO4/SiO2 and reduced to 10 µl 110 
in a nitrogen stream. After addition of the syringe standard 2,2',3,4,4',6-hexabromodiphenyl 111 
ether (Hexa-BDE 139 13C-UL labeled) the PBDEs were measured by means of 112 
HRGC/HRMS (high resolution gas chromatography/ high resolution mass spectrometry, 113 
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VG Autospec resp. Finnigan MAT 95 XL) using a DB 5 column for gas chromatographic 114 
separation. The quantification was performed by means of internal / external standards 115 
(isotope dilution). 116 
 117 
To assess the repeatability of the analytical technique one blind milk sample was analysed 118 
in duplicate by the laboratory.  The results were compared using the mean normalised 119 
difference (MND) obtained by taking the mean of the normalised differences [Norm. Diff. 120 
= │a-b│/ ((│a│+│b│)/2)] for congeners BDEs- -47, -99, -100, -153, and -183.  There was 121 
good agreement between the results of the duplicate samples with a MND of 6 %.  In 122 
addition, Eurofins/ERGO participated in and passed an inter-laboratory quality control/ 123 
quality assurance test with the Norwegian Institute of Public Health for PBDEs in human 124 
milk in 2006.        125 
 126 
2.1.2. Dust 127 
Dust samples were collected using a dedicated vacuum cleaner (Nilfisk King 520) that had 128 
multistage filtering in the exhaust system to avoid smaller particles passing through the 129 
cleaner which may have caused contamination at a site.  A new vacuum bag was used for 130 
each sample and one dust sample per house was obtained by vacuuming all floor coverings 131 
on the same level of the house where the air sampler would be deployed.  Following 132 
collection the contents were passed through a pre-cleaned 2 mm metal sieve with 1 g used 133 
for extraction and analysis.  The analytical methodology is as described below for air. 134 
 135 
2.1.3. Air 136 
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Passive sampling, using procedures described in Bartkow et al. (2005) was carried out to 137 
determine PBDE concentrations in air.  Polyurethane foam (PUF) discs (Tisch 138 
Environmental, Inc.; certified to be “flame retardant” free) were pre-extracted using 139 
accelerated solvent extraction (ASE) (ASE 300, Dionex) with acetone and hexane.  They 140 
were dried under a stream of nitrogen and stored in cleaned amber glass jars prior to field 141 
deployment.  The PUF discs were deployed partially sheltered within an inverted stainless 142 
steel “single bowl” chamber as described by Thomas et al. (2006), on the same day as dust 143 
collection.  The chamber was deployed at a height of approximately 2 metres, in the living 144 
area (room which usually contained a television, couches and dining room furniture) of the 145 
mother’s home for an average duration of 31 ± 2 days.   146 
 147 
PUF and dust samples were analysed at EnTox by HRGC/HRMS (HP 5890 II GC coupled 148 
to a Micromass AutoSpec mass spectrometer; splitless injection; injector temperature 280 149 
°C). Twenty-two PBDE congeners (BDE-17, 28, 47, 49, 66, 77, 85, 99, 100, 119, 126, 138, 150 
153, 154, 156, 183, 184, 191, 196, 197, 206, 207, 209) were separated on a Zebron ZB-151 
5MS column (10m × 0.18mm id., 0.18mm film thickness) with ultra-high purity helium 152 
carrier gas; flow rate 1.0 mL.min-1; temperature program 110 ºC for 3 min, 30 ºC min-1 to 153 
200 ºC, 20 ºC min-1 to 330 ºC and 330 ºC for 1 min; total run-time 14 min. The mass 154 
spectrometer operating conditions were: ion source and transfer line temperatures 270 °C; 155 
ionisation energy 38eV; electron multiplier voltage set to produce a gain of 106. Resolution 156 
was maintained at 5,000 (10% valley definition) throughout the sample sequence. Multiple 157 
ion detection (MID) experiments were performed in the electron impact mode with 158 
monitoring of the exact masses of appropriate ions for native and labelled compounds. 159 
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Individual congeners were identified using the GC retention time and ion abundance ratios 160 
with reference to internal standards. 161 
 162 
Criteria used for positive identification and quantification were: (i) retention time within 1 163 
second of the retention time of corresponding 13C12 internal standard; (ii) ion ratio ± 20% of 164 
the theoretical ion ratio; (iii)  signal to noise ratio > than 3:1 (iv) limit of detection (LOD) - 165 
the average level in field blanks + 3 SD (BDE-47,-99,-100,-206,-207,-209) or if not 166 
detected in field blanks was determined from calibration curves (intercept/slope) of native 167 
compounds to internal standard.  For all matrices, values below the limit of detection are 168 
prefixed by a “<” sign and were assigned a value of zero for calculation of sum PBDE 169 
concentrations.  For human milk the ΣPBDE value is the sum of the homologue groups for 170 
the mono, di, tri, tetra, penta, hexa, hepta, octa, nona and deca-BDEs  including BDEs- 1, -171 
2, -3, -7, -10, -13, -15, -17, -25, -28, -35, -47, -49, -66, -71, -75, -77, -85, -99, -100, -116, -172 
119, -126, -138, -140, -153, -154, -155, -156, -181, -183, -197, -203, -207 and -209.  The 173 
ΣPBDE value for air is the sum of BDEs- 47, -99 and -100 and for dust, is the sum of BDEs 174 
-47, -99, -100, -153, -183, -206 and -207. 175 
 176 
2.2 Statistical analysis 177 
Statistical analysis was mostly descriptive with means, medians, standard deviations and 178 
ranges reported.  For each congener, in each matrix, normality of the data was assessed.  In 179 
human milk, BDEs -47, -99, -153, -154, -209 and ΣPBDE results were normally distributed 180 
but BDE-183 was not.  In air and dust, all congeners were non-normally distributed.  Two 181 
tailed, Pearson’s (for normally distributed data) and Spearman’s (for non-normally 182 
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distributed data) correlation coefficients were determined to assess correlation between 183 
variables.  The conventional 5% cut-off was used to assess statistical significance of results.  184 
Statistical analysis was carried out using SPSS 16.0 for Windows.    185 
 186 
3. Results and discussion 187 
 188 
PBDEs were detected in all matrices as outlined in Table 1 and discussed below. 189 
 190 
3.1 Human milk 191 
PBDEs were detected in human milk with a mean ± standard deviation (median) ΣPBDE 192 
concentration of 10 ± 5.6 (12) ng/g lipid.  This is the first report of PBDE concentrations in 193 
individual samples in Australia. High variability in PBDE concentrations was evident with 194 
minimum and maximum ΣPBDE concentrations of 2.1 and 21 ng/g lipid, respectively 195 
(Table 2).  This is consistent with previously reported individual variability in PBDE 196 
concentrations (Birnbaum and Cohen Hubal 2006; Ryan et al. 2002; Schecter et al. 2003; 197 
She et al. 2007) and may be indicative that exposure to PBDEs is related to lifestyle and 198 
microenviroment or metabolic differences.  199 
 200 
The congener profile of eight samples was dominated by BDE-47 followed by -153, -100, -201 
99 and -183 and was consistent with previous reported profiles  (Baumann et al. 2003; 202 
Chao et al. 2007; Ingelido et al. 2007; Kalantzi et al. 2004; Lind et al. 2003; Schecter et al. 203 
2003).  The remaining  samples had BDE-153 concentrations greater than or equal to that 204 
of BDE-47, a profile which has been observed previously in The Faroe Islands (Fängström 205 
  10 
et al. 2004) and in selected samples from Germany (Raab et al. 2008).  The mean ± 206 
standard deviation (median) concentrations for BDEs- 47, -153, -100, -99 and -183 were 207 
4.4 ± 3.2 (4.2), 1.4 ± 0.5 (1.2), 1.2 ± 0.7 (1.1), 0.9 ± 0.5 (0.9) and 0.3 ± 0.5 (0.3) ng/g lipid, 208 
respectively with a detection frequency of 100 % for each of these congeners.  BDE-209 209 
was detected in 60 % of samples with mean ± standard deviation (median) concentrations 210 
of 0.3 ± 0.4 (0.3) ng/g lipid.  When concentrations of each congener were compared there 211 
were correlations between BDEs-47 and -99 (r=0.897, p<0.001); -47 and -100 (r=0.933, 212 
p<0.001); and -99 and -100 (r=0.945, p<0.001).  No significant correlation (p <0.05) was 213 
observable between BDE-209 and any other congeners.   214 
 215 
Basic information on maternal diets and lifestyle was provided by the questionnaire and 216 
revealed similar eating patterns between all participants.  All mothers had mixed diets, 217 
consumed meat and dairy more than twice a week and 60 % consumed fish once per week.  218 
One mother was an occasional smoker while all others were non-smokers, most mothers 219 
spent around one hour per day in a car and one reported the daily use of an air conditioner.  220 
No occupational exposure was reported.  Comparisons between PBDE concentrations and 221 
variables that may affect these concentrations were assessed.  Due to the small sample size, 222 
these relationships are interpreted with caution but provide an indication of important 223 
variables for investigation in future, large-scale studies.  Time spent at a computer ranged 224 
from 0.25 to 8 hours/day before the birth and 0.25 to 4 hours/day after the birth of the baby 225 
and was not correlated with PBDE concentrations.  It is worth noting that if a correlation 226 
between computer usage and PBDE concentrations did exist, it would most likely exist 227 
only with BDE-209, since penta- and octa-BDE were used sparingly on computer circuit 228 
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boards.    There was no relationship between PBDE concentrations in human milk by 229 
maternal or infant age at time of sample collection.  There were however, positive 230 
associations between BDE-47 and pre-pregnancy weight (r=0.750, p=0.012), pre-delivery 231 
weight (r=0.753, p=0.012) and maternal height (r=0.750, p=0.012) although not with body 232 
mass index (BMI).  BDE-100 concentrations were also correlated with height (r=0.655, 233 
p=0.040).  The reasons for these correlations are unclear at present.  It should be noted that 234 
the few correlations found do not follow from any hypothesis regarding exposure - they are 235 
equally, if not more, likely to be simply a coincidence and the result of a small sample size.  236 
There were no correlations between BDEs-99, -153, -154, -183 and -209 and maternal 237 
demographics.  BMI is the most investigated variable and the lack of correlation is 238 
consistent with previous findings (Chao et al. 2007; Lind et al. 2001; Wu et al. 2007).      239 
 240 
The concentrations of BDEs -47, -99, -100 and -153 in human milk in this study were 241 
compared with PBDE concentrations from a pool of human milk collected in 2002-2003 in 242 
Brisbane from 10 primiparous mothers, 2 – 8 weeks post partum (Toms et al. 2007).  The 243 
mean concentrations of BDEs -47, -99, -100 and -153 in the current study were 4.4, 0.9, 1.2 244 
and 1.4 ng/g lipid, respectively compared with 5.6,  2.2, 1.3 and 1.0 ng/g lipid from the 245 
pool.  Due to the different study design and analytical techniques, a direct comparison is 246 
difficult although it is noted that overall the average BDEs -47, -99, and -100 247 
concentrations in the present study are slightly lower than in the pool collected previously.  248 
While this may be the first indication of a decrease in the concentration in the Australian 249 
population, no such conclusions or even hypotheses can be offered due to the small sample 250 
size.  Also, there was no decrease in samples of human blood serum collected in Australia 251 
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in 2002-2003 and 2006-2007 (Toms et al. 2009 - submitted).  The inclusion of two 252 
multiparous mothers may have lowered the average concentrations although previously 253 
reported depuration rates for PBDEs in human milk indicate that the levels were unlikely to 254 
have been markedly lower after the second child (Hooper et al. 2007).  Unlike “traditional” 255 
persistent organic pollutants where concentrations decrease with subsequent lactational 256 
periods (Fürst et al. 1989), PBDEs do not show this same trend (Johnson-Restrepo et al. 257 
2007).  Further monitoring of human milk is required to assess whether a temporal trend 258 
exists and whether human body burden decreases following the cessation of penta- and 259 
octa-BDE product use.   260 
 261 
3.2 Air 262 
PBDE concentrations in air (pg/m3) were calculated using the PBDE amount accumulated 263 
in each PUF disc, an indoor PBDE sampling rate of 2.5 m3/day (Wilford et al. 2004) and 264 
the number of days the sampler was deployed.  This sampling rate was calculated by 265 
Wilford et al. (2004) using BDEs-17, -28, -47, -99 and -100 from a comparison of active 266 
versus passive samplers with one value for all congeners regardless of bromination.  BDEs 267 
-47 and -209 were detected in the field blank and for BDE-47, the amount (0.5 ng/PUF) 268 
detected in the blank was subtracted from the amount detected in exposed PUF samples 269 
prior to calculation of concentration in air.  Due to a relatively high proportion of BDE-209 270 
in the field blank relative to exposed PUF, it was not possible to quantify this congener.  271 
Given the high detection limit for some congeners and low sampling rates for indoor air, 272 
longer deployment periods would be necessary to reliably quantify BDE-209 and other 273 
congeners which may be present in relatively low concentrations.  PBDEs were detected in 274 
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all air samples with the mean ± standard deviation and median ΣPBDE (sum of BDEs – 47, 275 
-99 and  -100) concentration of 89 ± 94 and 56 pg/m3 (Table 3).  The congeners 276 
consistently detected in air samples were BDE-17, -28, -47, -99 and -100. In most samples, 277 
the congener profile was dominated by BDEs -47 and -99.  Outdoor sites (Kennedy et al. 278 
2008) and offices (indoors) studied previously in Brisbane had profiles dominated by BDE-279 
209 while in a small number of homes, the profile was inconsistent, with some dominated 280 
by BDE-209 and one by BDE-47 (Toms et al. 2008 - submitted).   281 
 282 
3.3 Dust 283 
PBDEs were detected in all samples of dust with the mean ± standard deviation (median) 284 
ΣPBDE concentration of 527 ± 872 (215) ng/g dust (Table 4).  The mean ± standard 285 
deviation (median) BDE-47 and -209 concentrations were 91 ± 124 (56) and 377 ± 438 286 
(291) ng/g dust, respectively.  BDE-183 was detected in 70 % of dust samples at 287 
concentrations less than 30 ng/g dust with the exception of one house.  The ΣPBDE 288 
concentration in dust at this house was the highest detected in the study with BDE-183 289 
detected at 950 ng/g dust.  This contributed 34 % to the ΣPBDE concentration of 2773 ng/g 290 
dust.  Across all dust samples, the average congener profile was dominated by BDE-209 291 
followed by BDEs -99, -183 and -47 with average contribution of BDEs -206 and -207 of 7 292 
% and 12 %, respectively.  The presence of BDEs -206 and -207 in dust samples is most 293 
likely due to degradation of BDE-209 (Stapleton and Dodder 2008 ) and determining these 294 
congeners means that total BDE-209 concentrations in dust are not underestimated.  Other 295 
studies of dust in Australia found similar overall PBDE concentrations and congener 296 
profiles where the median BDE-47 and -209 concentrations in household dust from 297 
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Brisbane in 2005 were 18 and 131 ng/g dust, respectively (Toms et al. 2008 - submitted) 298 
and also from Brisbane but in 2004 were 60 and 730 ng/g dust, respectively (Sjödin et al. 299 
2008).    300 
 301 
3.4 Comparison of human milk, air and dust 302 
Concentrations of PBDEs between human milk and air, human milk and dust; and air and 303 
dust were compared using scatterplots and correlation coefficients.  Due to the differences 304 
in number of congeners detected in each matrix, individual congeners rather than a sum 305 
PBDE concentration were used to assess correlation.  There was a significant correlation 306 
found for BDE-99 between human milk and air (r=0.661, p=0.038); and between BDE-183 307 
in human milk and BDE-153 in dust (r=0.697, p=0.025) (using Spearman’s correlation 308 
coefficients for non-normally distributed data).  From the data on matched samples, Wu et 309 
al. (2007) in the USA and Karlsson et al. (2007) in Sweden found positive associations 310 
between PBDE concentrations in human milk/ plasma and dust.  However, no association 311 
was found between plasma and air (Karlsson et al. 2007) or between human milk and dust 312 
from another study from the USA (Sharp and Lunder 2004).  It should be noted that the 313 
Karlsson et al. (2007) and Sharp and Lunder (2004) studies had only 5 and 10 homes, 314 
respectively, and so the lack of association found could be due to small sample size.  The 315 
lack of correlations between PBDE concentrations in human milk and dust could be an 316 
issue related to small sample size, or if not a sample size issue, other possible explanations 317 
may include: a) air and dust samples are not a good indicator of human body burden; b) 318 
food as well as additional unknown sources or exposure pathways make a greater 319 
contribution to a person’s body burden than air and dust; and c) individual metabolic 320 
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factors which influence the absorption and/ or elimination of PBDEs thus affecting body 321 
burden. 322 
 323 
3.5 Estimated infant PBDE intake 324 
Using the results of this study it is possible to estimate an infant’s daily intake of PBDEs.  325 
It is important to consider that there will be differences in PBDE intake of individual 326 
congeners from the different matrices and that this may alter as the impacts of the ban of 327 
the lower brominated products (penta- and octa-BDE commercial products) become 328 
evident. For each matched house/human milk sample, there was one human milk ingestion 329 
quantity, one dust ingestion quantity and one inhalation quantity, for each congener.  These 330 
quantities were combined to estimate the total intake of PBDEs for the infant living in the 331 
house.  Intake of BDE-47 via human milk ranged from 10 to 440 ng/day based on a 332 
consumption of 788 g/day human milk (Kent et al. 2006) and the individual lipid content of 333 
the milk samples.  Intake of BDE-47 via inhalation  ranged from to 0.2 to 1.1 ng/day using 334 
an inhalation rate of 4.5m3/day for <1 year olds (U.S. Environmental Protection Agency 335 
1997) and assuming 90 % of time spent indoors.   Intake of BDE-47 via dust ranged from 336 
1.2 to 22 ng/day using an ingestion rate of 50 mg per day for infants (Environmental 337 
Protection Agency).  For all matrices, an absorption rate of 100 % was assumed.  Total 338 
PBDE intake including all three pathways was calculated and the contribution of each 339 
pathway (percentage) was determined.  As would be expected based on the congener 340 
profiles, as the level of bromination increased the contribution of intake decreased via 341 
human milk and increased via dust (Figure 1).  For BDEs -47 and -209 the contribution of 342 
human milk to the total intake of PBDEs ranged from 49 – 99 % and 0 – 86 %, respectively 343 
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while the contribution of dust for these two congeners ranged from 1 – 51 % and 14 – 100 344 
%, respectively.   This may be important for future intervention strategies when exposure to 345 
the penta- and octa-BDE products has decreased but continues and/ or increases for the 346 
higher brominated decaBDE product.  The contribution of inhalation to total intake was 347 
minor and due to the problems detecting BDE-209 it was not possible to assess changes 348 
with level of bromination.  Due to the small sample size, these comparisons are made with 349 
caution and further investigation into exposure and body burden is needed before 350 
generalisations can be made.  It should be noted that the World Health Organization 351 
recommends breastfeeding in spite of the transient risk posed by POPs in human milk 352 
(World Health Organization 2007). 353 
 354 
4. Conclusion 355 
 356 
This is the first assessment of PBDEs in matched samples representing human body burden 357 
and exposure pathways in Australia.  PBDEs were detected in all matrices although there 358 
were few correlations between the concentrations in air and/ or dust with human milk.  This 359 
may be due to the small sample size or may indicate that other factors play an important 360 
role in exposure.  Average PBDE concentrations from these individual samples are similar 361 
to results from pooled human milk collected in Brisbane in 2002-2003 indicating that 362 
pooling may be an efficient, cost-effective strategy of assessing PBDE concentrations on a 363 
population basis.  In order to identify methods of reducing exposure, further research is 364 
required into the sources and exposure pathways of PBDEs.  In addition, it is necessary to 365 
continue monitoring of PBDEs in the human population as well as in the suggested 366 
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exposure matrices of food, dust and air in order to assess temporal trends of these chemicals 367 
in the Australian population. 368 
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Table 1. Mean ± standard deviation (median) concentrations of selected PBDEs 529 
(BDEs – 47, -99, -100, -153, -183 and -209) in human milk (ng/g lipid), dust (ng/g dust) 530 
and air (pg/m3).  531 
 532 
congener 
















47 4.4 ± 3.2 (4.2) 100 91 ± 124 (56) 100 55 ± 81 (25) 100 
99 0.9 ± 0.5 (0.9) 100 184 ± 256 (87) 100 36 ± 15 (32) 90 
100 1.2 ± 0.7 (1.1) 100 38 ± 47 (18) 100 6.4 ± 1.8 (6.4) 20 
153 1.4 ± 0.5 (1.2) 100 23 ± 40 (7.4) 100 n.d. 0 
183 0.3 ± 0.5 (0.1) 100 102 ± 297 (2.8) 70 n.d. 0 
209 0.3 ± 0.4 (0.31) 60 377 ± 438 (291) 100 n.a. 60 
n.d. not detected in any samples; n.a. not applicable 533 
534 
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Table 2. Concentrations (ng/g lipid) of selected PBDE congeners in human milk for 535 
each mother  536 
Sample Code BDE-47 BDE-99 BDE-100 BDE-153 BDE-183 BDE-209 ΣPBDEs 
1 5.0 1.6 1.7 1.5 0.4 < 0.2 12 
2 2.5 0.5 0.8 0.6 0.2 < 0.5 5.1 
3 3.9 1.1 1.2 1.2 0.1 1.4 11 
4 5.4 0.8 1.6 1.1 0.04 0.5 12 
5 12 1.9 2.3 1.3 0.04 0.3 21 
6 1.7 0.4 0.5 1.7 0.1 < 0.2 5.1 
7 6.8 1.4 1.9 1.2 0.1 0.6 14 
8 0.6 0.2 0.3 0.9 0.02 < 0.2 2.1 
9 4.3 0.9 1.0 1.9 1.4 0.5 14 
10 1.6 0.3 0.4 1.1 0.2 < 0.2 4.4 
ΣPBDEs  is sum of all homologue groups 537 
538 
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Table 3. Concentrations (pg/m3) of selected PBDE congeners in indoor air for each 539 
mother’s home 540 
Sample code BDE-47 BDE-99 BDE-100 BDE-153 BDE-183 BDE-209 ΣPBDEs  
1 60 51.1 <1.3 <1.3 <1.3 n.a. 111 
2 21 <1.3 <1.3 <1.3 <1.3 n.a. 21 
3 18 46 <1.4 <1.4 <1.4 n.a. 64 
4 50 31 <1.3 <1.3 <1.3 n.a. 81 
5 280 53 7.7 <1.1 <1.1 n.a. 341 
6 4.1 32 <1.4 <1.4 <1.4 n.a. 36 
7 16 21 <1.2 <1.2 <1.2 n.a. 37 
8 13 20 <1.3 <1.3 <1.3 n.a. 34 
9 54 53 5.1 <1.3 <1.3 n.a. 112 
10 30 19 <1.3 <1.3 <1.3 n.a. 49 
n.a. not applicable;  ΣPBDEs is the sum of BDEs-47, -99 and -100 541 
542 
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Table 4. Concentrations (ng/g dust) of selected PBDE congeners in dust for each 543 
mother’s home 544 







1 61 132 30 9.4 31 193 296 498 
2 434 862 155 139 948 289 2756 3062 
3 25 52 11 2.6 <0.002 104 106 219 
4 24 75 15 1.0 11 95 139 240 
5 83 82 19 6.8 <0.002 359 234 614 
6 25 49 12 5.2 2.0 299 127 441 
7 24 92 16 8.0 28 1585 344 2019 
8 82 102 24 5.6 3.6 293 244 546 
9 52 36 10 8.3 0.2 137 119 262 
10 106 364 83 52 <0.002 421 695 1141 
ΣPBDEs is the sum of BDEs- 47, -99, -100, -153, -183, -206 and -207 545 
 546 
547 






























Figure 1. Average contribution (%) of each intake pathway (human milk, air and 549 
dust) to total PBDE intake for an infant. 550 
